[Form 4] SOPHiA GENETICS SA Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
SOPHiA GENETICS SA disclosed that Chief Financial Officer George Cardoza received new equity awards. He was granted 164,671 share options with an exercise price of $5.04 per ordinary share, expiring on April 2, 2036, and 112,936 ordinary shares as restricted stock units (RSUs). These are compensation-related grants, not open-market purchases.
The RSUs vest 25% on April 2, 2027, with the remaining 75% vesting in equal quarterly installments through April 2, 2030. The share options vest 25% on April 2, 2027, then in equal monthly installments through April 2, 2030. After these grants, Cardoza directly holds 112,936 ordinary shares and options for 164,671 shares, aligning his compensation further with long-term company performance.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
CARDOZA GEORGE
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option (Right to Buy) | 164,671 | $0.00 | -- |
| Grant/Award | Ordinary Shares | 112,936 | $0.00 | -- |
Holdings After Transaction:
Share Option (Right to Buy) — 164,671 shares (Direct);
Ordinary Shares — 112,936 shares (Direct)
Footnotes (1)
- Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. 25% of the RSUs will vest on April 2, 2027, and the remaining 75% will vest in equal quarterly installments through April 2, 2030. The share option vests and becomes exercisable as to 25% of the ordinary shares on April 2, 2027, and then in equal monthly installments through April 2, 2030.
Key Figures
Share options granted: 164,671 options
Option exercise price: $5.04 per share
Option expiration: April 2, 2036
+5 more
8 metrics
Share options granted
164,671 options
Grant to CFO George Cardoza on April 2, 2026
Option exercise price
$5.04 per share
Exercise price for 164,671 share options
Option expiration
April 2, 2036
Expiration date of granted share options
RSUs granted
112,936 shares
Restricted stock unit grant to CFO on April 2, 2026
RSU initial vesting
25% on April 2, 2027
First vesting tranche of RSU grant
Remaining RSU vesting
75% through April 2, 2030
Vests in equal quarterly installments
Post-grant share holdings
112,936 ordinary shares
Direct holdings after RSU grant
Post-grant option holdings
164,671 options
Direct option position after grant
Key Terms
restricted stock unit ("RSU"), 2021 Equity Incentive Plan, vesting, exercise price, +1 more
5 terms
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan."
2021 Equity Incentive Plan financial
"RSU grant made under the Issuer's 2021 Equity Incentive Plan."
vesting financial
"25% of the RSUs will vest on April 2, 2027, and the remaining 75% will vest in equal quarterly installments through April 2, 2030."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion or exercise price of 5.0400 per ordinary share for the option grant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
